Heart Failure Clinic, Division of Geriatric Medicine and Intensive Care Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Heart Failure Clinic, Division of Geriatric Medicine and Intensive Care Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
J Am Med Dir Assoc. 2020 Dec;21(12):1803-1807. doi: 10.1016/j.jamda.2020.10.017. Epub 2020 Oct 16.
Because of the Coronavirus Disease 2019 (COVID-19) pandemic, we were forced to cancel scheduled visits for nearly 150 patients followed in our heart failure (HF) outpatient clinic. Therefore, we structured a telephone follow-up, developing a standardized 23-item questionnaire from which we obtained the Covid-19-HF score. The questionnaire was built to reproduce our usual clinical evaluation investigating a patient's social and functional condition, mood, adherence to pharmacological and nonpharmacological recommendations, clinical and hemodynamic status, pharmacological treatment, and need to contact emergency services. The score was used as a clinical tool to define patients' clinical stability and timing of the following telephone contact on the basis of the assignment to progressively increasing risk score groups: green (0-3), yellow (4-8), and red (≥9). Here we present our experience applying the score in the first 30 patients who completed the 4-week follow-up, describing baseline clinical characteristics and events that occurred in the period of observation.
由于 2019 年冠状病毒病(COVID-19)大流行,我们被迫取消了近 150 名在我们心力衰竭(HF)门诊就诊的患者的预约。因此,我们构建了电话随访,从我们获得的 Covid-19-HF 评分中制定了一个标准化的 23 项问卷。该问卷旨在复制我们通常的临床评估,调查患者的社会和功能状况、情绪、对药物和非药物建议的依从性、临床和血液动力学状况、药物治疗以及联系急诊服务的需求。该评分被用作临床工具,根据分配给风险评分逐渐增加的组(绿色(0-3)、黄色(4-8)和红色(≥9))来定义患者的临床稳定性和下一次电话联系的时间。在这里,我们介绍了在完成 4 周随访的最初 30 名患者中应用该评分的经验,描述了基线临床特征和观察期间发生的事件。